e-learning
resources
Virtual 2021
07.09.2021
Clinical problems associated with cough, pleura and respiratory health status
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Morphine use in the treatment of dyspnea in terminally ill patients.
L. Zanol Lorencini Stanzani (Brasília, Brazil), M. Marques (Porto Alegre, Brazil), M. Martins (Brasília, Brazil), W. Vieira (Brasília, Brazil), F. Amorim (Brasília, Brazil), R. Carvalho (São Paulo, Brazil)
Source:
Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Session:
Clinical problems associated with cough, pleura and respiratory health status
Session type:
E-poster
Number:
3135
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Zanol Lorencini Stanzani (Brasília, Brazil), M. Marques (Porto Alegre, Brazil), M. Martins (Brasília, Brazil), W. Vieira (Brasília, Brazil), F. Amorim (Brasília, Brazil), R. Carvalho (São Paulo, Brazil). Morphine use in the treatment of dyspnea in terminally ill patients.. 3135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Morphine and oxygen use in terminally ill patients with dyspnea in Brazil.
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021
How to improve dyspnoea and other symptoms in terminally ill respiratory patients
Source: International Congress 2016 – When respiratory disease come to an end
Year: 2016
The practice of sedation in critically ill patients
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016
Year: 2017
Uncomplicated dementia in very elderly patients can be a cause of NIV treatment failure
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Preferences, communications and decisions in terminally ill respiratory patients
Source: Annual Congress 2007 - Clinical year in review
Year: 2007
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Steroid use in elderly critically ill COVID-19 patients
Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021
Year: 2021
Iloprost delivery and efficacy in critically ill patients
Source: Annual Congress 2007 - Problems in intensive care medicine
Year: 2007
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19.
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021
Reasons of intensive care unit admission in COPD patients
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Continuous epidural ropivacaine infusion reduces intra-abdominal pressure, postoperative pain and normalizes lungs' mechanical changes in critically ill children after major abdominal operation
Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children
Year: 2013
Which tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008
Why tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008
Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Treating anxious expectations can improve dyspnoea in patients with COPD
Source: Eur Respir J, 50 (3) 1701352; 10.1183/13993003.01352-2017
Year: 2017
The use of betablockers in chronic airway disease causing acute respiratory failure in intensive care unit
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept